APA (7th ed.) Citation

X, L., S, X., W, Z., R, J., & W, Z. (2019). Targeted Fe-doped silica nanoparticles as a novel ultrasound–magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Li, Xia S, Zhou W, Ji R, and Zhan W. Targeted Fe-doped Silica Nanoparticles as a Novel Ultrasound–magnetic Resonance Dual-mode Imaging Contrast Agent for HER2-positive Breast Cancer. Dove Medical Press, 2019.

MLA (8th ed.) Citation

X, Li, et al. Targeted Fe-doped Silica Nanoparticles as a Novel Ultrasound–magnetic Resonance Dual-mode Imaging Contrast Agent for HER2-positive Breast Cancer. Dove Medical Press, 2019.